13-disease-research-notes-research

This package is a single, self-contained computational research corpus covering 300 diseases and medical conditions. Each disease has its own dedicated research document, generated by running the Alchemy Data V2 elemental correlation engine against a curated 36,456-compound library and mapping the matches onto the biochemistry of the target condition. Each document is structured identically across all 300 diseases so a reader can pivot from one condition to another without re-learning the layout. Every document contains a theoretical serum formulation, a primary transformation pathway plus three alternative pathways, a multi-degree probability matrix, quality-control checkpoints, and a full elemental-composition breakdown. Roughly one disease in five (~19 %) carries an additional pharmaceutical cross-reference layer with FDA-approved drug data where public data allowed. The total documentation footprint is approximately 450,000 lines of research text across the 300 disease files and ~28 supporting documents, plus 58 Python analysis scripts, plus a Chemical Cooker interoperability bridge that emits 45 physical G-code recipes for a separately-acquired robotic cooker platform.

The intended reader is a pharmaceutical or biotech R&D team, a contract research organisation, an academic medical centre, an IP holding company, or an independent inventor who wants a systematic elemental-correlation starting point across the non-opioid disease space. The intended use is as a research substrate — a starting map that shortens the “where do I even begin?” phase of compound-candidate screening — not as a treatment protocol. The scoring inside the package is mathematical overlap, not clinical efficacy. That distinction is repeated everywhere it matters inside the package and is the single most important thing to understand before opening the disc.

The corpus is a systematic, computational search for elemental patterns that overlap with disease mechanisms. It works by (1) categorising each of the 300 target conditions into one of 16 medical categories; (2) mapping each category to a profile of chemically-relevant elements — e.g. cardiac conditions to H, C, N, O, Mg, K, Ca; endocrine/thyroid conditions to H, C, N, O, I, Se; neurological conditions to H, C, N, O, Mg, Ca; blood conditions to H, C, N, O, Fe, Cu; (3) searching the Alchemy Data V2 database for compounds whose elemental composition matches those profiles; (4) generating transformation pathways, probability matrices, and theoretical serum recipes for the matches; and (5) cross-referencing against published pharmaceutical databases where such references are available. The output is a per-disease report that a downstream researcher can use as a first-pass literature-substitute for “what elemental candidates are worth looking at for condition X, and by what mechanism might they act.”

The corpus is not drug discovery, clinical validation, efficacy testing, medical advice, or a substitute for the standard scientific pipeline (synthesis → in vitro → in vivo → clinical trials → regulatory approval). “Discovery scores” reflect database coverage and mechanism overlap, not therapeutic probability. “Probability” values are mathematical calculations from the Alchemy system, not clinical success rates. “Serum recipes” are theoretical formulations, not validated pharmaceutical preparations. Sharing elements between a compound and a disease mechanism does not mean the compound treats the disease. Only ~19 % of the 300 conditions carry any verified pharmaceutical cross-reference in the package; the remaining ~81 % rest on Alchemy Data V2 elemental correlation alone and require independent scientific validation before any therapeutic reading is drawn from them.

Every one of the 300 core conditions in the numbered list is a condition that is typically managed without opioids as primary treatment. That framing is deliberate: the corpus was scoped away from pain-management pharmacology to keep the elemental-correlation work focused on mechanism analysis rather than analgesic substitution.

Each of the 300 NNN-Disease-Name-CURE.md files opens with the standard disclaimer paragraph and then follows a fixed nine-section layout so a reader can jump straight to the section they need. A typical file is 1,200 – 1,636 lines long. The sections are:

Alchemy Data V2 is Christopher Gabriel Brown's correlation-based elemental analysis database. It holds 36,456 elemental combinations, each carrying its transformation pathways, synthesis methods, and probability scores. The database is not a drug library; it is an elemental-combination catalogue with cross-linked transformation data. The engine drives every match in this package.

Category 1 — Infectious Diseases (001–050): Influenza Type A; Influenza Type B; Influenza Type C; Common Cold (Rhinovirus); COVID-19 (SARS-CoV-2); HIV/AIDS; Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis D; Hepatitis E; Tuberculosis (Pulmonary); Tuberculosis (Extrapulmonary); Pneumonia (Bacterial); Pneumonia (Viral); Pneumonia (Fungal); Meningitis (Bacterial); Meningitis (Viral); Meningitis (Fungal); Encephalitis; Sepsis; Urinary Tract Infection; Strep Throat; Scarlet Fever; Diphtheria; Pertussis (Whooping Cough); Tetanus; Cholera; Typhoid Fever; Malaria; Dengue Fever; Yellow Fever; Zika Virus; West Nile Virus; Lyme Disease; Rocky Mountain Spotted Fever; Chlamydia; Gonorrhea; Syphilis; Herpes Simplex Virus Type 1; Herpes Simplex Virus Type 2; Varicella-Zoster (Chickenpox); Varicella-Zoster (Shingles); Epstein-Barr Virus (Mononucleosis); Cytomegalovirus; Human Papillomavirus (HPV); Rotavirus; Norovirus; Giardiasis; Amebiasis.

Category 2 — Cardiovascular Diseases (051–075): Hypertension (Primary); Hypertension (Secondary); Coronary Artery Disease; Myocardial Infarction; Angina Pectoris; Heart Failure (Systolic); Heart Failure (Diastolic); Atrial Fibrillation; Atrial Flutter; Supraventricular Tachycardia; Ventricular Tachycardia; Bradycardia; Heart Block (First Degree); Heart Block (Second Degree); Heart Block (Third Degree); Arrhythmia (Unspecified); Cardiomyopathy (Dilated); Cardiomyopathy (Hypertrophic); Cardiomyopathy (Restrictive); Pericarditis; Endocarditis; Myocarditis; Aortic Stenosis; Mitral Valve Prolapse; Peripheral Artery Disease.

Category 3 — Respiratory Diseases (076–100): Asthma (Mild); Asthma (Moderate); Asthma (Severe); COPD; Emphysema; Chronic Bronchitis; Bronchiectasis; Cystic Fibrosis; Pulmonary Fibrosis; Sarcoidosis; Pneumothorax; Pleural Effusion; Pulmonary Embolism; Pulmonary Hypertension; Sleep Apnea (Obstructive); Sleep Apnea (Central); Allergic Rhinitis; Sinusitis (Acute); Sinusitis (Chronic); Laryngitis; Pharyngitis; Tonsillitis; Bronchitis (Acute); Bronchitis (Chronic); Respiratory Syncytial Virus (RSV).

Category 4 — Gastrointestinal Diseases (101–125): GERD; Peptic Ulcer (Gastric); Peptic Ulcer (Duodenal); Crohn's Disease; Ulcerative Colitis; Irritable Bowel Syndrome (IBS); Celiac Disease; Diverticulitis; Diverticulosis; Gastritis; Gastroenteritis; Colitis; Chronic Constipation; Chronic Diarrhea; Hemorrhoids; Anal Fissure; Gallstones; Cholecystitis; Pancreatitis (Acute); Pancreatitis (Chronic); Autoimmune Hepatitis; Cirrhosis (Alcoholic); Cirrhosis (Non-alcoholic); NAFLD; NASH.

Category 5 — Endocrine Disorders (126–150): Diabetes Mellitus Type 1; Diabetes Mellitus Type 2; Prediabetes; Gestational Diabetes; Hypothyroidism; Hyperthyroidism; Hashimoto's Thyroiditis; Graves' Disease; Thyroid Nodules; Goiter; Addison's Disease; Cushing's Syndrome; Hyperaldosteronism; Pheochromocytoma; Acromegaly; Gigantism; Dwarfism; Growth Hormone Deficiency; Diabetes Insipidus; SIADH; Hyperparathyroidism; Hypoparathyroidism; Osteomalacia; Rickets; Metabolic Syndrome.

Category 6 — Neurological Disorders (151–175): Epilepsy (Generalized); Epilepsy (Focal); Multiple Sclerosis (Relapsing-Remitting); Multiple Sclerosis (Primary Progressive); Multiple Sclerosis (Secondary Progressive); Parkinson's Disease; Alzheimer's Disease; Dementia (Vascular); Dementia (Lewy Body); Dementia (Frontotemporal); Amyotrophic Lateral Sclerosis (ALS); Huntington's Disease; Tourette Syndrome; ADHD; Autism Spectrum Disorder; Cerebral Palsy; Bell's Palsy; Trigeminal Neuralgia; Migraine (With Aura); Migraine (Without Aura); Tension Headache; Cluster Headache; Restless Legs Syndrome; Narcolepsy; Chronic Insomnia.

Category 7 — Musculoskeletal Disorders (176–200): Osteoarthritis (Knee); Osteoarthritis (Hip); Osteoarthritis (Hand); Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Gout; Pseudogout; Osteoporosis; Osteopenia; Fibromyalgia; Myositis; Polymyalgia Rheumatica; Bursitis; Tendinitis; Carpal Tunnel Syndrome; Tennis Elbow; Golfer's Elbow; Rotator Cuff Injury; Scoliosis; Kyphosis; Lordosis; Osteomalacia; Rickets; Paget's Disease of Bone.

Category 8 — Dermatological Conditions (201–225): Psoriasis (Plaque); Psoriasis (Guttate); Psoriasis (Pustular); Atopic Dermatitis (Eczema); Contact Dermatitis; Seborrheic Dermatitis; Acne Vulgaris; Rosacea; Vitiligo; Alopecia Areata; Urticaria (Hives); Angioedema; Dyshidrotic Eczema; Nummular Eczema; Keratosis Pilaris; Seborrheic Keratosis; Actinic Keratosis; Basal Cell Carcinoma; Squamous Cell Carcinoma; Melanoma; Fungal Skin Infections; Bacterial Skin Infections; Viral Skin Infections; Warts; Molluscum Contagiosum.

Category 9 — Hematologic Disorders (226–250): Iron Deficiency Anemia; B12 Deficiency Anemia; Folate Deficiency Anemia; Hemolytic Anemia; Aplastic Anemia; Sickle Cell Disease; Thalassemia; Hemophilia A; Hemophilia B; Von Willebrand Disease; Thrombocytopenia; Thrombocytosis; Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Chronic Lymphocytic Leukemia; Chronic Myeloid Leukemia; Hodgkin's Lymphoma; Non-Hodgkin's Lymphoma; Multiple Myeloma; Polycythemia Vera; Essential Thrombocythemia; Myelofibrosis; Coagulation Disorders; Bleeding Disorders; Blood Clotting Disorders.

Category 10 — Psychiatric Disorders (251–275): Major Depressive Disorder; Persistent Depressive Disorder (Dysthymia); Bipolar Disorder Type I; Bipolar Disorder Type II; Cyclothymic Disorder; Generalized Anxiety Disorder; Panic Disorder; Social Anxiety Disorder; OCD; PTSD; Schizophrenia; Schizoaffective Disorder; Delusional Disorder; Brief Psychotic Disorder; Borderline Personality Disorder; Antisocial Personality Disorder; Narcissistic Personality Disorder; Avoidant Personality Disorder; Dependent Personality Disorder; Anorexia; Bulimia; Binge Eating; ADD; ADHD; Autism Spectrum Disorder.

Category 11 — Renal Disorders (276–290): Chronic Kidney Disease Stage 1; Stage 2; Stage 3; Stage 4; Stage 5; Acute Kidney Injury; Nephrotic Syndrome; Nephritic Syndrome; Polycystic Kidney Disease; Glomerulonephritis; Pyelonephritis; Kidney Stones (Calcium); Kidney Stones (Uric Acid); Kidney Stones (Struvite); Renal Failure.

Category 12 — Hepatic Disorders (291–300): Hepatitis A; Hepatitis B (Chronic); Hepatitis C (Chronic); Autoimmune Hepatitis; Primary Biliary Cholangitis; Primary Sclerosing Cholangitis; Wilson's Disease; Hemochromatosis; Alpha-1 Antitrypsin Deficiency; Liver Cirrhosis.

Extended appendix — Autoimmune: Systemic Lupus Erythematosus; Sjögren's Syndrome; Scleroderma; Myasthenia Gravis; Guillain-Barré Syndrome; Vasculitis; Polymyositis; Dermatomyositis. Genetic: Down Syndrome; Turner Syndrome; Klinefelter Syndrome; Marfan Syndrome; Ehlers-Danlos Syndrome; Neurofibromatosis; Tuberous Sclerosis; Fragile X Syndrome. Oncological (non-opioid managed): Breast Cancer (Early Stage); Prostate Cancer (Early Stage); Thyroid Cancer; Non-Melanoma Skin Cancer; Leukemia (Various Types); Lymphoma (Various Types). Metabolic: Obesity; Metabolic Syndrome; Hyperlipidemia; Hypercholesterolemia; Hypertriglyceridemia; Gout; Porphyria.

The package includes a compatibility bridge that converts the 45 highest-confidence novel compound formulations (across 10 medical categories) from Alchemy Data V2 into Chemical Cooker recipe JSON plus G-code. If a buyer separately owns a Chemical Cooker robotic platform, the bridge lets that hardware physically prepare the theoretical formulations under its own laboratory supervision. Purchasing this package does not convey any right to the Chemical Cooker hardware or platform; that product is separately acquired. The bridge is inspection-only if the buyer does not own the Cooker.

Each compound emits two files — cure_<category>_<name>_<formula>.json (Cooker recipe JSON) and cure_<category>_<name>_<formula>.gcode (Cooker G-code) — plus a top-level MANIFEST.json. The JSON schema conforms to 16-chemical-cooker/platform/lite_alchemy/schema.json and carries source, compound name, enhanced & base formulas, disease category, match score, probability, therapeutic potential (theoretical), a formulation block (elements, volumes in µL, vessels, heat in Celsius, heat time in seconds, stir flag), the disclaimer, the safety reference, the step sequence (move / dispense / heat / stir / wait), and cooker metadata. Default deck positions are defined for reservoir_1–4, well_1–2, and waste; these are override-able in the Cooker platform config. Modes are: representative (one recipe per category = 10), all (every compound = 45), and inspect (list categories, list a category's compounds, top-N by probability, G-code for one).

The package ships 58 Python analysis scripts (60 counting utility helpers) under _internal/scripts/, plus a PowerShell orchestrator. The scripts are what generated the 300 disease documents in the first place; a buyer may re-run them, modify them, extend the disease-to-element mapping, or point them at a different underlying compound database.

This package ships on a single Blu-ray disc, posted to the delivery address on your order. The archive on the disc is AES-256 encrypted; the passphrase is sent separately, by email, once the disc is despatched — so the disc alone is of no use to anyone who intercepts it.

Discs are despatched by tracked, signed-for post. Allow 5 business days for mastering and verification before despatch.

© 2026 Christopher Gabriel Brown. All rights reserved.